In this context, it has been demonstrated that treatments with either a GLP1/Estrogen (GLP1/E) conjugate, a unimolecular GLP1/GIP (gastric inhibitory peptide) dual agonist, or a GLP1/GIP/Glucagon triagonist, markedly reduced body weight and improved diabetic complications, including hyperinsulinemia, in preclinical models of obesity in males 33,34,35
Importantly, patterns of age-related muscle loss appear to be different between sexes, with men demonstrating a greater rate of relative loss in muscle mass with age and females having a greater prevalence for sarcopenialikely due to males having a higher muscular reserve compared to females (de Jong et al., 2023)
Medical director at Phoenix and Raven explains why brand-name Ozempic still leads despite Health Canada approvals When Health Canada approved generic semaglutide in late April, Phoenix and Raven, two digital telemedicine platforms focused on lifestyle medicine, had inventory in patients' hands within weeks and pricing the generic at $125 per month
Glia (2007) 55(5):45362
It restores the legal status quo for topical and cosmetic compounding of one of the most prescribed peptides in the dermatology and aesthetic medicine space, and it sets up a Pharmacy Compounding Advisory Committee review before the end of February 2027 that will eventually decide whether GHK-Cu lands on the permanent 503A bulks list at all
Looking for simple ways to boost your protein intake